OLNEY, Md., Nov. 27 /PRNewswire/ -- Datasci, LLC and etrials Worldwide, Inc. announced today that their pending patent litigation has been settled. The lawsuit, which is related to Datasci’s U.S. Patent Number 6,496,827, concerned the collection and validation of clinical trial data. Under the terms of the settlement agreement, etrials has entered into a non-exclusive licensing arrangement with Datasci on a going-forward basis.
“We are thrilled to have granted a license to etrials,” said Dr. Marc Kozam, co-inventor of the patent. “Use of this patent will help manufacturers move drugs to market one to three years faster than would otherwise be the case through the use of other methodologies. Furthermore, this innovation provides researchers with the tools they need to identify adverse events virtually in real time, a clear win-win for consumers and drug makers.”
etrials is the sixth company to be granted a non-exclusive license for use of this technology by Datasci. As a result of strong financial results achieved by licensees utilizing the technology, Datasci estimates that additional licenses will be granted over the next five years.
About Datasci, LLC
Founded in 2004 by doctors Marc Kozam and Louie Korman, Datasci is committed to assisting clinical research organizations with electronic data capture methodologies that increase the speed and safety of bringing new pharmaceuticals to market. For more information, please contact Leanne Jernigan at (202) 973-1344 or ljernigan@levick.com.
CONTACT: Leanne Jernigan for Datasci, LLC, +1-202-973-1344,
ljernigan@levick.com
